‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.
Compounded weight-loss drugs raise serious patient safety concerns
Written on 15/05/2026
Jeremy Maggs
Read full article
